BIOTE CORP -A (BTMD) Stock Overview
USA - NASDAQ:BTMD - US0906831039 - Common Stock
BTMD Key Statistics, Chart & Performance
The current stock price of BTMD is 2.89 USD. In the past month the price decreased by -3.34%. In the past year, price decreased by -43.66%.
BTMD Latest News, Press Relases and Analysis
BTMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 51.11 | 781.26B | ||
| JNJ | JOHNSON & JOHNSON | 18.34 | 458.55B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.76 | 258.24B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.73 | 252.36B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 13.65 | 235.32B | ||
| MRK | MERCK & CO. INC. | 11.36 | 218.53B | ||
| PFE | PFIZER INC | 7.3 | 140.77B | ||
| SNY | SANOFI-ADR | 14.34 | 125.85B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.51 | 89.21B | ||
| GSK | GSK PLC-SPON ADR | 9.67 | 86.97B | ||
| ZTS | ZOETIS INC | 23.46 | 64.68B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 50.04 | 44.25B |
Related stock screener links
About BTMD
Company Profile
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 217 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Company Info
BIOTE CORP -A
1875 W. Walnut Hill Ln #100, Floor 5
Irving TEXAS US
Employees: 217
Phone: 19724869346
BIOTE CORP -A / BTMD FAQ
Can you describe the business of BIOTE CORP -A?
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 217 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
What is the stock price of BIOTE CORP -A today?
The current stock price of BTMD is 2.89 USD. The price decreased by -1.7% in the last trading session.
What is the dividend status of BIOTE CORP -A?
BTMD does not pay a dividend.
What is the ChartMill rating of BIOTE CORP -A stock?
BTMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
On which exchange is BTMD stock listed?
BTMD stock is listed on the Nasdaq exchange.
How is the valuation of BIOTE CORP -A (BTMD) based on its PE ratio?
The PE ratio for BIOTE CORP -A (BTMD) is 2.95. This is based on the reported non-GAAP earnings per share of 0.98 and the current share price of 2.89 USD.
Can you provide the short interest for BTMD stock?
The outstanding short interest for BIOTE CORP -A (BTMD) is 3.22% of its float.
BTMD Technical Analysis
BTMD Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to BTMD. BTMD has only an average score on both its financial health and profitability.
BTMD Financial Highlights
Over the last trailing twelve months BTMD reported a non-GAAP Earnings per Share(EPS) of 0.98. The EPS increased by 366.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.73% | ||
| ROA | 29.87% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BTMD Forecast & Estimates
12 analysts have analysed BTMD and the average price target is 5.51 USD. This implies a price increase of 90.7% is expected in the next year compared to the current price of 2.89.
For the next year, analysts expect an EPS growth of 166.59% and a revenue growth -2.93% for BTMD